Clinical Trial

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

Study acronym: EASYlight
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized controlled trial is to investigate the effect of esketamine versus placebo on the NRS score for chronic pelvic pain. Secondary endpoints are to assess pain scores, side-effects, quality of life, depressive symptoms and pain coping.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-12-07; most recent amendment 2025-04-08.
Status change: Not Yet Recruiting → Recruiting 2024-02-22
Trial Details
NCT Number NCT06161805
Lead Sponsor Reinier de Graaf Groep
Conditions Endometriosis, Chronic Pelvic Pain Syndrome
Enrollment 56 participants
Start Date 2024-03-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-11